Prospective Efficacy and Safety of a Novel Bypassing Agent, FVIIa/FX Mixture (MC710) for Hemophilia Patients with Inhibitors

QR Code

Prospective Efficacy and Safety of a Novel Bypassing Agent, FVIIa/FX Mixture (MC710) for Hemophilia Patients with Inhibitors

None

Saved in:

Bibliographic Details
Main Authors:	Tomokiyo, Kazuhiko, Nakatomi, Yasushi, Hamamoto, Takayoshi, Nakagaki, Tomohiro
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/34463
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FX : a three dimensional graphical visualisation tool and macro language users manual /
by: Laslett, D.
Published: (1994)

Hemophilia Inhibitors Prevalence, Causes and Diagnosis
by: Owaidah, Tarek M.
Published: (2012)

First Hints of Pressure Waves in a Helical Extragalactic Jet: S5 0836+710
by: Manel Perucho
Published: (2014-12-01)

ANALISIS AERODINAMIKA DAN AEROAKUSTIK AIRFOIL WORTMANN FX63-137
by: Muhammad Zidane Athaya Zulkipli, et al.
Published: (2025-05-01)

Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
by: Quentin Van Thillo, et al.
Published: (2025-07-01)

Screening of hemophilia patients for detection of inhibitors to fibrillation factors and development of personified treatment
by: N. I. Zozulya, et al.
Published: (2008-12-01)

Research progress on clinical application of anti-tissue factor pathway inhibitor in hemophilia
by: XIAO Jianwen, YI Weijia
Published: (2025-04-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

Population Evolution in Hemophilia
by: Chung, Myung-Hoon
Published: (2012)

Advantages of palatal cystotomy, demanded for treating cystic structures in the patient with inhibitors hemophilia A
Published: (2020-04-01)

Clinical Characteristics of Hemophilia Today
by: M. Y. Ledyaev, et al.
Published: (2010-06-01)

Enhancing Financial Resilience: A Critical Analysis of FX Derivative Risk Disclosures and the Path Forward with the Delta-Transparency Framework
by: Zeng Wenqian
Published: (2025-01-01)

Modeling Stylized Facts in FX Markets with FINGAN-BiLSTM: A Deep Learning Approach to Financial Time Series
by: Dong-Jun Kim, et al.
Published: (2025-06-01)

Experience of induction of immune tolerance in patients with inhibitor form of hemophilia A in the presence of negative prognostic factors
by: N. I. Zozulya
Published: (2008-12-01)

Inhibitor development and clinical characteristics in children with severe hemophilia A in the ATHN 8 US cohort study
by: Courtney D. Thornburg, et al.
Published: (2025-08-01)

Intracranial Hemorrhage in a Patient of Hemophilia A with Factor VIII Inhibitors Positive: A Case Report
by: Melvin K. Ninan, et al.

CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran
Published: (2025-07-01)

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Genotype-Phenotype Interaction Analyses in Hemophilia
by: Jaloma-Cruz, Ana Rebeca, et al.
Published: (2012)

Marstacimab for the Treatment of Hemophilia A or B
by: Mahlangu J
Published: (2025-06-01)

Comparative analysis of retrospective and current evaluation of life quality for patients with inhibitor form of hemophilia treated with Novoseven medication
by: N. I. Zozulya, et al.
Published: (2008-12-01)

CO36 | Inhibitor titer at diagnosis and clinical course in acquired hemophilia A: a single-center experience
Published: (2025-07-01)

Chapter 1 Profiling of Mutations in the F8 and F9, Causative Genes of Hemophilia A and Hemophilia B"
by: Hwang, Sung Ho, et al.
Published: (2012)

Evaluation of Anti-Infectious Activity of Bioconjugates Based on Quantum Dots CdTe / Cd MPA 710 and Levofloxacin against Staphylococcal Corneal Infection. Experimental Research
by: V. O. Ponomarev, et al.
Published: (2023-01-01)

CO34 | Evaluation of emicizumab concentration and thrombin generation in a cohort of severe hemophilia A patients with and without inhibitor
Published: (2025-07-01)

Using Factor VII in Hemophilia Gene Therapy
by: Kazemi, Bahram
Published: (2011)

General Considerations on Clinical Trials of Hemophilia Medicines
by: Zh. I. Avdeeva, et al.
Published: (2020-03-01)

“Bridegroom of blood”- A biblical reference to hemophilia?
by: Joshua M. Kosowsky
Published: (2025-07-01)

Getting closer to hemophilia gene therapy for all?
by: Ulrike M. Reiss
Published: (2025-07-01)

Psychological Factors that Influence the Health of People with Hemophilia
by: Luis Horacio Aguiar Palacios, et al.
Published: (2025-06-01)

The McGuffin
by: Bowen, John, 1924-
Published: (1984)

The use of fibrinolysis inhibitors in cardiac surgery with cardiopulmonary bypass (literature review)
by: V. Yu. Medvedeva, et al.
Published: (2024-08-01)

A Cascade of Encoder–Decoder with Atrous Convolution and Ensemble Deep Convolutional Neural Networks for Tuberculosis Detection
by: Noppadol Maneerat, et al.
Published: (2025-06-01)

Otogenic Sinus Thrombosis and Hemophilia: A Clinical Case
by: I. M. Veshkurtseva, et al.
Published: (2023-06-01)

Stopping the bleed: A hemophilia B success story
by: Bhavya Krishna, et al.
Published: (2025-01-01)

McCartney, the biography /
by: Flippo, Chet
Published: (1988)

McNally's gamble /
by: Sanders, Lawrence, 1920-
Published: (1997)

NONSPECIFIC ULCERATIVE COLITIS AND SEVERE HEMOPHILIA A COMBINATION IN CHILDREN
by: E.I. Alieva, et al.
Published: (2010-03-01)

METHODOLOGY OF THE DRUGS MARKET VOLUME MODELING ON THE EXAMPLE OF HEMOPHILIA A
by: N. B. Molchanova
Published: (2015-12-01)